- Tools
- Downloads
- Links
- Community
- About
- Help
FB2026_01
,
released March 12, 2026
[78E5-78E5];[79A2-79A2];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
78E5;79A2
Breakpoint based on release 3 sequence coordinate from Thibault et al., 2004, Supplementary Table 2 (FBrf0174227) or 3 (FBrf0174228), converted to release 5 coordinate.
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
Inferred to overlap with: Df(3L)BSC284.
The presence of P+PBac{XP5.WH5}BSC450 was verified using the PCR methods and primers described in FBrf0175003.
Exelixis, Inc. determined the insertion site of P{XP}d03182 to be Release 3 genomic coordinate 21796569 on chromosome arm 3L. This corresponds to 79A2 on the Release 3 and Release 5 genome maps. The predicted position of PBac{WH}f00993 on the Release 5 map is 78E5. Consequently, the cytological breakpoints of Df(3L)BSC450 are
predicted to be 78E5;79A2.